Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
CATHETER PRECISION INC (VTAK) Stock Price & Overview
NYSEARCA:VTAK • US74933X7084
Current stock price
0.95 USD
0 (-0.19%)
At close:
0.95 USD
0 (0%)
After Hours:
The current stock price of VTAK is 0.95 USD. Today VTAK is down by -0.19%. In the past month the price increased by 2.15%. In the past year, price decreased by -81.48%.
VTAK Key Statistics
52-Week Range0.7906 - 15.6807
Current VTAK stock price positioned within its 52-week range.
1-Month Range0.7906 - 1.28
Current VTAK stock price positioned within its 1-month range.
- Market Cap
- 2.556M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -19.20
- Dividend Yield
- N/A
VTAK Stock Performance
Today
-0.19%
1 Week
+2.16%
1 Month
+2.15%
3 Months
-51.03%
Longer-term
6 Months -61.22%
1 Year -81.48%
2 Years -99.00%
3 Years N/A
5 Years N/A
10 Years N/A
VTAK Stock Chart
VTAK Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to VTAK. When comparing the yearly performance of all stocks, VTAK is a bad performer in the overall market: 97.85% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
VTAK Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to VTAK. VTAK may be in some trouble as it scores bad on both profitability and health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
VTAK Earnings
Next Earnings DateMay 12, 2026
Last Earnings DateMar 31, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise -86.27%
VTAK Forecast & Estimates
7 analysts have analysed VTAK and the average price target is 38.76 USD. This implies a price increase of 3980% is expected in the next year compared to the current price of 0.95.
For the next year, analysts expect an EPS growth of 49.21% and a revenue growth 168.42% for VTAK
Analysts
Analysts85.71
Price Target38.76 (3980%)
EPS Next Y49.21%
Revenue Next Year168.42%
VTAK Financial Highlights
Over the last trailing twelve months VTAK reported a non-GAAP Earnings per Share(EPS) of -19.2. The EPS increased by 91.79% compared to the year before.
Income Statements
Revenue(TTM)819.00K
Net Income(TTM)-17.18M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -108.34% | ||
| ROE | -243.53% | ||
| Debt/Equity | 0.48 |
Chartmill High Growth Momentum
EPS Q2Q%84.21%
Sales Q2Q%59.73%
EPS 1Y (TTM)91.79%
Revenue 1Y (TTM)95%
VTAK Ownership
Ownership
Inst Owners10.18%
Shares2.69M
Float2.31M
Ins Owners14.02%
Short Float %3.5%
Short Ratio0.06
VTAK Industry Overview
VTAK operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
60/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
22%
Outperformed 22% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 2.4%
- New Lows
- 14.2%
- Average ROE
- 17.2%
- Average Profit Margin
- 20.3%
- Average Operating Margin
- 22.5%
- Average P/E
- 28.1
- Average Fwd P/E
- 27.3
- Average Debt/Equity
- 0.5
VTAK Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.25 | 162.529B | ||
| ABT | ABBOTT LABORATORIES | 14.24 | 157.763B | ||
| SYK | STRYKER CORP | 17.41 | 120.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.31 | 85.619B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.9 | 48.141B | ||
| IDXX | IDEXX LABORATORIES INC | 38.32 | 44.539B | ||
| BDX | BECTON DICKINSON AND CO | 10.94 | 42.438B | ||
| RMD | RESMED INC | 16.7 | 31.148B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.74 | 27.761B | ||
| DXCM | DEXCOM INC | 20.18 | 22.918B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.11 | 15.956B | ||
| PEN | PENUMBRA INC | 63.83 | 12.837B | ||
| GMED | GLOBUS MEDICAL INC - A | 20.03 | 12.197B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About VTAK
Company Profile
Catheter Precision, Inc. engages in the design, manufacture, and sale of medical devices and technologies for cardiac electrophysiology. The company is headquartered in Fort Mill, South Carolina and currently employs 22 full-time employees. The company went IPO on 2018-09-27. The firm is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The firm's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. The company is developing technology for the treatment of acute decompensated heart failure.
Company Info
IPO: 2018-09-27
CATHETER PRECISION INC
1670 Highway 160 West, Suite 205
Fort Mill SOUTH CAROLINA US
Employees: 22
Phone: 13026587581
CATHETER PRECISION INC / VTAK FAQ
What does CATHETER PRECISION INC do?
Catheter Precision, Inc. engages in the design, manufacture, and sale of medical devices and technologies for cardiac electrophysiology. The company is headquartered in Fort Mill, South Carolina and currently employs 22 full-time employees. The company went IPO on 2018-09-27. The firm is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The firm's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. The company is developing technology for the treatment of acute decompensated heart failure.
What is the current price of VTAK stock?
The current stock price of VTAK is 0.95 USD. The price decreased by -0.19% in the last trading session.
Does VTAK stock pay dividends?
VTAK does not pay a dividend.
What is the ChartMill technical and fundamental rating of VTAK stock?
VTAK has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the market expecting VTAK stock to perform?
7 analysts have analysed VTAK and the average price target is 38.76 USD. This implies a price increase of 3980% is expected in the next year compared to the current price of 0.95.
What is CATHETER PRECISION INC worth?
CATHETER PRECISION INC (VTAK) has a market capitalization of 2.56M USD. This makes VTAK a Nano Cap stock.
Can you provide the upcoming earnings date for CATHETER PRECISION INC?
CATHETER PRECISION INC (VTAK) will report earnings on 2026-05-12.